Like many diseases, atherosclerotic cardiovascular disease is driven by the activity of inflammatory cells. Using molecular imaging to target and analyze populations of inflammatory cells is one promising strategy to non-invasively assess atherosclerosis progression. However, current molecular imaging contrast agents are not suited for such targeted imaging applications. Nanomaterial-based strategies...
In an era of personalized medicine, the clinical community has become increasingly focused on understanding diseases at the cellular and molecular level. Magnetic resonance imaging (MRI) is a powerful imaging modality for acquiring anatomical and functional information. However, it has limited applications in field of molecular imaging due to low...
Coronary magnetic resonance angiography (MRA) is emerging as a promising method for noninvasive diagnosis of coronary artery diseases. Nonetheless, acquisition of large-coverage high-resolution coronary artery images requires free-breathing acquisition. Accurately measuring and correcting respiratory motion has been one of the major challenges to coronary MRA. Diaphragmatic navigator (NAV), the current...